December 13 Biotech Update

Not a ton of news as the year closes down. It seems like the market wants to whiplash investors as we bounce around with no clear trends. It does not.

Bria-IMT Combination Study with KEYTRUDA®: What the Early Data Show

BriaCell presented some data from the ongoing Phase IIa combination clinical trial of Bria-IMT™ with Merck’s (NYSE: MRK) KEYTRUDA® [(pembrolizumab)], as listed in ClinicalTrials.gov as NCT03328026, in advanced breast cancer.

December 11 Biotech Update

The market did a lot better to start the week than I would have thought and that strength continues today. At this point, I think everyone does not really trust.

December 7 Biotech Update

The market can always surprise and I was surprised yesterday with the sector strength. The broader market did better than I expected but the sector clearly outperformed. It is only.

December 6 Biotech Update

China is back in the news and for good or ill, the sector fundamentals do not matter. Right now it is all about China and the broader market will pull.

December 4 Biotech Update

Yesterday was a good day but not as broad based as one would have hoped. Today will be telling in that the confusion over the China “trade deal” has only.

December 3 Biotech Update

It is certainly a great start to the week with generally good news from ASH, merger Monday, and easing trade tensions. If we do not get a gap and run.

November 29 Biotech Update

We are at an interesting place for the sector. The XBI is approaching the upper end of the downtrend, which has been acting as resistance. I am not totally convinced.

November 28 Biotech Update

Yesterday as a bad day for the sector as it was red with a positive broader market backdrop. To be fair it was a rather odd day in the sector.

November 26 Biotech Update

After a nice long holiday break, I figured there might be some more news to start the week but apparently not. The sector is off to a good start but.

November 20 Biotech Update

I guess we did not get the turn around that could have been a positive sign. There is still a chance for a turnaround Tuesday as we gap lower at.

November 19 Biotech Update

This should be a relatively slow week but with ASH late breaking abstracts coming out later, it might not be completely devoid of news. There is a little more hope.

Bria-IMT Combination Study with KEYTRUDA®: What to Know and Why

In a previous interview, BriaCell (TSX:BCT.V) (OTCQB:BCTXF) (or the Company)’s President and CEO, Dr. Bill Williams cited as a near-term catalyst data from the Company’s ongoing Phase IIa combination clinical.

November 15 Biotech Update

Today is an important day for the sector. We are at very long term support (the 200 week MA) that has rarely been breached (occasionally but never in a sustained.

November 13 Biotech Update

We are getting what I suspect is a dead cat bounce after the trouncing yesterday. The recent lows need to hold but there really seems to be nothing in terms.

November 12 Biotech Update

A rough start to the week. The market just feels heavy and looks like it wants to break through the recent lows. It looked for a little like it wanted.

November 8 Biotech Update

Not a lot going on but there are a couple of quick points I want to make today. 1. AKAO is having the completely predictable slow antibiotic launch. You will.

November 7 Biotech Update

The midterm elections are over and now we have a couple hour break before the 2020 presidential campaigning begins. The split congress is likely positive for the markets as they.

November 6 Biotech Update

While there are certainly other things happening in the market, I want to focus today on ONCS as I think there are important take aways not only about the data.

November 5 Biotech Update

We are entering the heart of the SMID earning season and while it could have an impact on the individual stock, it usually does not have major impacts more broadly..

Browsing 20 / articles